Skip to content

AZN

AstraZeneca PLC

Income statement

Income statement
Line, in USD20252024202320222021202020192018201720162015
Revenue58.7B54.1B45.8B44.4B37.4B26.6B24.4B22.1B22.5B23.0B24.7B
Cost of revenue
10.6B10.2B8.3B12.4B12.4B5.3B4.9B4.9B4.3B4.1B4.6B
Gross profit48.1B43.9B37.5B32.0B25.0B21.3B19.5B17.2B18.1B18.9B20.1B
14.2B13.6B10.9B9.8B9.7B6.0B6.1B5.9B5.8B5.9B6.0B
19.9B20.0B19.2B18.4B15.2B11.3B11.7B10.0B10.2B9.4B11.1B
Other operating expenses
198M303M—————————
Operating income13.7B10.0B8.2B3.8B1.1B5.2B2.9B3.4B3.7B4.9B4.1B
Non-operating income
−1.34B−1.31B−1.29B−1.26B−1.32B−1.25B−1.38B−1.39B−1.45B−1.35B−1.05B
Pretax income12.4B8.7B6.9B2.5B−265M3.9B1.5B2.0B2.2B3.6B3.1B
Taxes
2.18B1.66B0.94B−0.79B−0.38B0.72B0.21B−0.16B−0.77B53M0.24B
Net income10.2B7.0B6.0B3.3B112M3.2B1.3B2.2B3.0B3.5B2.8B
Diluted EPS6.549.007.624.220.164.882.063.404.745.524.46
Diluted shares1.56B781.5M781.0M780.0M713.5M656.5M650.5M633.5M633.5M633.0M632.5M
Revenue growth+8.6%+18.0%+3.3%+18.5%+40.6%+9.2%+10.4%−1.7%−2.3%−6.9%—
Gross margin81.9%81.1%82.0%72.1%66.8%80.1%79.8%77.7%80.8%82.1%81.2%
Operating margin23.4%18.5%17.9%8.5%2.8%19.4%12.0%15.3%16.4%21.3%16.7%
Net margin17.4%13.0%13.0%7.4%0.3%12.0%5.5%9.8%13.4%15.2%11.4%